PHARMACOKINETICS OF LEVODOPA AND CARBIDOPA IN RATS FOLLOWING DIFFERENT ROUTES OF ADMINISTRATION

被引:30
|
作者
BREDBERG, E [1 ]
LENNERNAS, H [1 ]
PAALZOW, L [1 ]
机构
[1] UPPSALA UNIV,DEPT BIOPHARMACEUT & PHARMACOKINET,UPPSALA,SWEDEN
关键词
LEVODOPA; CARBIDOPA; RAT; PHARMACOKINETICS; ABSORPTION;
D O I
10.1023/A:1018970617104
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
This study examined the pharmacokinetics of levodopa and carbidopa in the rat after different modes of administration. The drugs were given simultaneously by the intravenous, intraarterial, oral, duodenal, and intraperitoneal routes, as single doses. The ratio of levodopa to carbidopa given was always 4:1. Two iv doses (5 and 15 mg/kg of levodopa) were given to test for nonlinearity. Three ip doses of levodopa were given (5, 7.5, and 15 mg/kg), and the 15 mg/kg dose was given in three volumes (2, 4, and 20 mL/kg). One oral dose and two intraduodenal doses of 15 mg/kg were given. The drugs were dissolved in saline in one of the intraduodenal doses and suspended in 1.8% methylcellulose in the other. The elimination of levodopa was nonlinear. There was a comparatively high degree of interindividual variability in absorption with the oral route, but this was substantially reduced when levodopa was given intraduodenally. There was also much less variability with the intraperitoneal route compared to the oral, and the degree of absorption was generally high. There was a significantly higher extent and slower rate of absorption when levodopa was administered ip in a large volume of vehicle. These results suggest that the oral route may not be the optimal method of delivering levodopa to patients who have a fluctuating response and that a continuous delivery system via the intraperitoneal or intraduodenal routes might be a better alternative.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 50 条
  • [31] EFFECT OF ENTACAPONE, A COMT INHIBITOR, ON THE PHARMACOKINETICS AND METABOLISM OF LEVODOPA AFTER ADMINISTRATION OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA IN VOLUNTEERS
    AHTILA, S
    KAAKKOLA, S
    GORDIN, A
    KORPELA, K
    HEINAVAARA, S
    KARLSSON, M
    WIKBERG, T
    TUOMAINEN, P
    MANNISTO, PT
    CLINICAL NEUROPHARMACOLOGY, 1995, 18 (01) : 46 - 57
  • [32] Uptake and biodistribution of rizatriptan to blood and brain following different routes of administration in rats
    Wang, Chun
    Quan, Li-Hui
    Guo, Yi
    Liu, Chun-Yu
    Liao, Yong-Hong
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 337 (1-2) : 155 - 160
  • [33] PHARMACOKINETICS OF SULFADIAZINE UPON DIFFERENT ROUTES OF ADMINISTRATION IN RABBIT
    ERNI, W
    RITSCHEL, WA
    PHARMACEUTICA ACTA HELVETIAE, 1976, 51 (11): : 326 - 330
  • [34] Pharmacokinetics of Accordion Pill™ Carbidopa/Levodopa Following Multiple Doses in Patients With Parkinson's Disease
    Olanow, C.
    Stocchi, F.
    Leinonen, M.
    Navon, N.
    Meckler, J.
    Gendreau, R.
    MOVEMENT DISORDERS, 2019, 34
  • [35] Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats
    Chen, J
    Ping, QN
    Guo, JX
    Chu, XZ
    Song, MM
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2006, 27 (02) : 53 - 59
  • [36] Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety
    Ahmed A. Othman
    Krai Chatamra
    Mohamed-Eslam F. Mohamed
    Sandeep Dutta
    Janet Benesh
    Masayoshi Yanagawa
    Masahiro Nagai
    Clinical Pharmacokinetics, 2015, 54 : 975 - 984
  • [37] Unwanted effects and interaction of intrajejunal levodopa/carbidopa administration
    Jost, Wolfgang H.
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 (04) : 447 - 458
  • [38] Pharmacokinetics of Fluoxetine in Rhesus Macaques following Multiple Routes of Administration
    Sawyer, E. K.
    Howell, L. L.
    PHARMACOLOGY, 2011, 88 (1-2) : 44 - 49
  • [39] Pharmacokinetics and pharmacodynamics of levodopa/carbidopa cotherapies for Parkinson's disease
    Mueller, Thomas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (05) : 403 - 414
  • [40] THE EFFECT OF AGE ON THE PHARMACOKINETICS OF LEVODOPA ADMINISTERED ALONE AND IN THE PRESENCE OF CARBIDOPA
    ROBERTSON, DRC
    WOOD, ND
    EVEREST, H
    MONKS, K
    WALLER, DG
    RENWICK, AG
    GEORGE, CF
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (01) : 61 - 69